Candesartan cilexetil for heart failure
Record ID 32006000926
English
Authors' objectives:
Candesartan cilexetil, hydrolyzed to its active form candesartan, is an angiotensin II receptor blocker (ARB) that is intended for the treatment of hypertension and for the treatment of heart failure (HF) (New York Heart Association [NYHA] Class II-IV) in patients with left ventricular systolic dysfunction (left ventricular ejection fraction [LVEF] # 40%) to reduce cardiovascular death and to reduce HF hospitalizations. In addition, candesartan may be used in combination with an angiotensin-converting enzyme (ACE) inhibitor.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=3586
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Benzimidazoles
- Biphenyl Compounds
- Heart Failure
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.